Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
supersaturated calcium phosphate rinse
- Development stage
- Phase 4
- Lead developer
- EUSA Pharma
- Administration
- Oral
01
Overview
Supersaturated calcium phosphate rinse is a medical solution used to treat dry mouth (xerostomia) and oral mucositis. It works by increasing the amount of saliva in the mouth, which makes it easier to speak and swallow. The rinse contains high concentrations of calcium and phosphate ions that help permeate intercellular spaces of injured epithelial tissues to promote healing. It also contains sodium bicarbonate which helps buffer salivary pH. The solution moistens, lubricates, and cleans the oral cavity, acting as a partial substitute for natural saliva.
- Brand names
- CaphosolNeutraSalSalivaMAX
- Other names
- SSCPR
Beyond the preview
Go deeper on supersaturated calcium phosphate rinse.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on supersaturated calcium phosphate rinse.